Richard Rosenquist Selected Research

Complementarity Determining Regions (Complementarity Determining Region)

1/2019	Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations.
12/2010	Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.
11/2004	Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia.
2/2004	V(H)3-21 gene usage in chronic lymphocytic leukemia--characterization of a new subgroup with distinct molecular features and poor survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Rosenquist Research Topics

Disease

72	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 03/2002
35	Neoplasms (Cancer) 01/2022 - 11/2002
17	Lymphoma (Lymphomas) 01/2022 - 05/2004
12	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 04/2002
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 06/2005
7	Disease Progression 11/2020 - 08/2004
7	Pain (Aches) 01/2020 - 01/2010
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2002
6	Leukemia 01/2021 - 01/2005
5	B-Cell Lymphoma (Lymphoma, B Cell) 06/2014 - 04/2007
4	Rheumatoid Arthritis 01/2017 - 04/2008
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017 - 12/2009
3	Residual Neoplasm 01/2017 - 10/2002
3	Burns 03/2014 - 01/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 09/2009
2	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 01/2018
2	Neuralgia (Stump Neuralgia) 01/2018 - 03/2014
2	Trisomy (Trisomies) 01/2018 - 08/2003
2	Blister (Bulla) 11/2014 - 04/2008
2	Wounds and Injuries (Trauma) 01/2012 - 07/2004
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 07/2005 - 01/2005
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Postoperative Pain 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Hyperalgesia 01/2018
1	Neuroinflammatory Diseases 01/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017
1	Philadelphia Chromosome 01/2017
1	Low Back Pain (Lumbago) 11/2016
1	Stroke (Strokes) 05/2015
1	Paralysis (Palsy) 05/2015

Drug/Important Bio-Agent (IBA)

36	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 03/2002
29	AntigensIBA 01/2019 - 04/2002
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2008
10	Biological ProductsIBA 01/2022 - 08/2003
7	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2018 - 11/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2005
6	Pharmaceutical PreparationsIBA 01/2018 - 04/2003
5	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2011
5	Immunoglobulin Variable RegionIBA 07/2005 - 04/2003
4	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2010
4	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2019 - 02/2004
4	Immunoglobulin M (IgM)IBA 01/2019 - 07/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2009
4	EpitopesIBA 01/2016 - 06/2003
3	Complement System Proteins (Complement)IBA 01/2022 - 01/2012
3	fludarabineIBA 12/2019 - 02/2016
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016 - 10/2002
3	Messenger RNA (mRNA)IBA 06/2015 - 02/2008
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2020 - 03/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 02/2016
2	Rituximab (Mabthera)FDA Link 12/2019 - 02/2016
2	ibrutinibIBA 01/2019 - 05/2018
2	Amino Acids FDA Link 01/2017 - 02/2004
2	MicroRNAs (MicroRNA)IBA 01/2016 - 06/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2015 - 04/2010
2	AutoantigensIBA 11/2014 - 05/2004
2	AntibodiesIBA 11/2014 - 04/2008
2	Antigen Receptors (Antigen Receptor)IBA 08/2013 - 08/2009
2	SteroidsIBA 01/2012 - 04/2010
2	Surface Antigens (Surface Antigen)IBA 07/2005 - 01/2003
2	MitogensIBA 07/2005 - 08/2003
2	Indicators and Reagents (Reagents)IBA 04/2005 - 08/2004
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	ribosomal protein S15IBA 01/2021
1	IgKIBA 01/2021
1	ChemokinesIBA 01/2021
1	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 01/2021
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	Morphine (MS Contin)FDA LinkGeneric 01/2020
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Ketamine FDA LinkGeneric 01/2020
1	PlacebosIBA 01/2020
1	venetoclaxIBA 10/2019
1	Opiate AlkaloidsIBA 01/2019
1	serum P-component (CIt)IBA 01/2019
1	idelalisibIBA 05/2018
1	Biocompatible Materials (Biomaterials)IBA 02/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017
1	Histone MethyltransferasesIBA 06/2016
1	Cytidine DeaminaseIBA 06/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2015
1	To autoantigenIBA 11/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2014
1	Interleukin-8 (Interleukin 8)IBA 10/2014
1	Blood Proteins (Serum Proteins)IBA 06/2014

Therapy/Procedure

21	Therapeutics 01/2022 - 05/2004
3	Pain Management 01/2020 - 03/2014
3	Drug Therapy (Chemotherapy) 01/2018 - 11/2002
3	Analgesia 03/2014 - 07/2004
2	Precision Medicine 01/2022 - 01/2022
1	Genomic Medicine 01/2022
1	Palliative Care (Palliative Therapy) 11/2021
1	Radiofrequency Ablation 11/2016